This inventor holds 1 USPTO granted patent. Top assignee: Solvay Sa. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Alan S Cross: Innovator in Pharmaceutical Treatments
Introduction
Alan S Cross is a notable inventor based in Washington, DC, recognized for his contributions to the field of pharmaceuticals. He has developed innovative solutions aimed at improving patient outcomes, particularly in critical medical conditions.
Latest Patents
Alan S Cross holds a patent for a pharmaceutical product designed for the treatment of sepsis. This invention involves the use of an antibody to tumor necrosis factor-α (anti-TNF) and an antibody to bacterial lipopolysaccharide (anti-LPS). When used together in a neutropenic rat model of sepsis, these antibodies have been shown to enhance survival rates compared to using either antibody alone. The pharmaceutical products that include these components are therefore valuable in the therapy of sepsis.
Career Highlights
Throughout his career, Alan has made significant strides in pharmaceutical research and development. His work has been instrumental in advancing treatments that address severe medical conditions, showcasing his commitment to improving healthcare.
Collaborations
Alan has collaborated with esteemed colleagues such as Jerald C Sadoff and Steven Michael Opal. These partnerships have contributed to the success of his research and the development of innovative treatments.
Conclusion
Alan S Cross exemplifies the spirit of innovation in the pharmaceutical industry, with his patent for a sepsis treatment highlighting his dedication to enhancing patient care. His work continues to inspire advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile